The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–271 of 271
Expression of the H-ras proto-oncogene is controlled by alternative splicing
Cohen, J. B., Broz, S. D., & Levinson, A. D. (1989) · Cell · doi:10.1016/0092-8674(89)90427-3 · Cited by 105
Alternative splicing regulation of telomerase: a new paradigm?
Wong, M. S., Wright, W. E., & Shay, J. W. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.07.006 · Cited by 103
ASTD: The Alternative Splicing and Transcript Diversity database
Koscielny, G., Texier, V. L., Gopalakrishnan, C., Kumanduri, V., Riethoven, J.-J. M., Nardone, F., Stanley, E., Fallsehr, C., Hofmann, O., Kull, M., et al. (2008) · Genomics · doi:10.1016/j.ygeno.2008.11.003 · Cited by 102
Sveen, A., Ågesen, T. H., Nesbakken, A., Rognum, T. O., Lothe, R. A., & Skotheim, R. I. (2011) · Genome Medicine · doi:10.1186/gm248 · Cited by 102
Self-citationAn integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth
Adler, A. S., McCleland, M. L., Yee, S. F., Yaylaoglu, M., Hussain, S., Cosino, E., Quiñones, G., Modrusan, Z. D., Seshagiri, S., Torres, E., et al. (2014) · Genes & Development · doi:10.1101/gad.237206.113 · Cited by 100
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression
Ferrarese, R., Harsh, G. R., Yadav, A. K., Bug, E., Maticzka, D., Reichardt, W., Dombrowski, S. M., Miller, T. E., Masilamani, A. P., Dai, F., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68836 · Cited by 99
French, P. J., Peeters, J. K., Horsman, S., Duijm, E. J., Siccama, I., van den Bent, M. J., Luider, T. M., Kros, J. M., van der Spek, P. J., & Smitt, P. A. E. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2869 · Cited by 99
Choi, J. W., Kim, D. G., Lee, A.-E., Kim, H., Lee, J. Y., Kwon, N. H., Shin, Y. K., Hwang, S.-K., Chang, S.-H., Cho, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001351 · Cited by 96
Alternative RNA splicing regulation in the testis
Elliott, D. J., & Grellscheid, S. N. (2006) · Reproduction · doi:10.1530/rep-06-0147 · Cited by 95
A Global View of Cancer-Specific Transcript Variants by Subtractive Transcriptome-Wide Analysis
He, C., Zhou, F., Zuo, Z., Cheng, H., & Zhou, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004732 · Cited by 92
Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway
Thorsen, K., Mansilla, F., Schepeler, T., Øster, B., Rasmussen, M. H., Dyrskjøt, L., Karni, R., Akerman, M., Krainer, A. R., Laurberg, S., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002998 · Cited by 92
Himeji, D., Horiuchi, T., Tsukamoto, H., Hayashi, K., Watanabe, T., & Harada, M. (2002) · Blood · doi:10.1182/blood.v99.11.4070 · Cited by 91
Bates, D. O., Catalano, P. J., Symonds, K. E., Varey, A. H. R., Ramani, P., O'Dwyer, P. J., Giantonio, B. J., Meropol, N. J., Benson, A. B., & Harper, S. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2223 · Cited by 91
Natural Trans-spliced mRNAs Are Generated from the Human Estrogen Receptor-α (hERα) Gene
Flouriot, G., Brand, H., Séraphin, B., & Gannon, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203513200 · Cited by 90
Zhao, Q., Caballero, O. L., Davis, I. D., Jonasch, E., Tamboli, P., Yung, W. K. A., Weinstein, J. N., Strausberg, R. L., & Yao, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3708 · Cited by 82
U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Qian, J., Yao, D., Lin, J., Qian, W., Wang, C.-Z., Chai, H., Yang, J. C., Li, Y., Deng, Z., Ma, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045760 · Cited by 78
Agrawal, S., & Eng, C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi492 · Cited by 76
Végran, F., Boidot, R., Oudin, C., Riedinger, J., Bonnetain, F., & Lizard‐Nacol, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0725 · Cited by 76
Göransson, M., Andersson, M. K., Forni, C., Ståhlberg, A., Andersson, C. X., Olofsson, A., Mantovani, R., & Åman, P. (2008) · Oncogene · doi:10.1038/onc.2008.378 · Cited by 75
Shitashige, M., Naishiro, Y., Idogawa, M., Honda, K., Ono, M., Hirohashi, S., & Yamada, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.007 · Cited by 75
A survey of software for genome-wide discovery of differential splicing in RNA-Seq data
Hooper, J. E. (2014) · Human Genomics · doi:10.1186/1479-7364-8-3 · Cited by 74
Sundaram, S. K., Shankar, S., DeRoo, S. C., Iyer, M. K., Palanisamy, N., Chinnaiyan, A. M., & Kumar‐Sinha, C. (2012) · Neoplasia · doi:10.1593/neo.12914 · Cited by 73
Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer
Vivas‐Mejía, P. E., Rodriguez‐Aguayo, C., Han, H., Shahzad, M. M. K., Valiyeva, F., Shibayama, M., Chávez‐Reyes, A., Sood, A. K., & Lopez‐Berestein, G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0233 · Cited by 73
Gene Expression and Isoform Variation Analysis using Affymetrix Exon Arrays
Bemmo, A., Benovoy, D., Kwan, T., Gaffney, D. J., Jensen, R. V., & Majewski, J. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-529 · Cited by 73
Acquired Mutations That Affect Pre-mRNA Splicing in Hematologic Malignancies and Solid Tumors
Scott, L. M., & Rebel, V. I. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt257 · Cited by 73
Global Properties and Functional Complexity of Human Gene Regulatory Variation
Gaffney, D. J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003501 · Cited by 69
Plowman, S. J., Berry, R. L., Bader, S. A., Luo, F., Arends, M. J., Harrison, D. J., Hooper, M. L., & Patek, C. E. (2006) · PubMed · Cited by 69
Yadav, S. P., Hao, H., Yang, H., Kautzmann, M.-A. I., Brooks, M., Nellissery, J. K., Klocke, B., Seifert, M., & Swaroop, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt609 · Cited by 69
Alternative mRNA Splicing of Liver Intestine-Cadherin in Hepatocellular Carcinoma
Wang, X. Q., Luk, J. M., Leung, P. P., Wong, B. W., Stanbridge, E. J., & Fan, S. T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.483.11.2 · Cited by 69
Wang, H., Zhou, M., Shi, B., Zhang, Q., Jiang, H., Sun, Y., Liu, J., Zhou, K., Yao, M., Gu, J., et al. (2011) · Neoplasia · doi:10.1593/neo.101744 · Cited by 68
Increased Rac1b Expression Sustains Colorectal Tumor Cell Survival
Matos, P., & Jordan, P. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0008 · Cited by 68
MSEA: detection and quantification of mutation hotspots through mutation set enrichment analysis
Jia, P., Wang, Q., Chen, Q., Hutchinson, K. E., Pao, W. J., & Zhao, Z. (2014) · Genome biology · doi:10.1186/preaccept-1822061407140231 · Cited by 67
Lenos, K., Grawenda, A. M., Lodder, K., Kuijjer, M. L., Teunisse, A. F. A. S., Repapi, E., Grochola, L. F., Bartel, F., Hogendoorn, P. C. W., Wuerl, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0215 · Cited by 66
Rouas‐Freiss, N., Bruel, S., Menier, C., Marcou, C., Moreau, P., & Carosella, E. D. (2005) · International Journal of Cancer · doi:10.1002/ijc.21151 · Cited by 63
Higher gene expression variability in the more aggressive subtype of chronic lymphocytic leukemia
Ecker, S., Pancaldi, V., Rico, D., & Valencia, A. (2015) · Genome Medicine · doi:10.1186/s13073-014-0125-z · Cited by 63
Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer
Femel, J., Huijbers, E. J. M., Saupe, F., Cedervall, J., Zhang, L., Roswall, P., Larsson, E., Olofsson, H., Pietras, K., Dimberg, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2628 · Cited by 62
Regulation of Telomerase Alternative Splicing: A Target for Chemotherapy
Wong, M. S., Chen, L., Foster, C., Kainthla, R., Shay, J. W., & Wright, W. E. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.011 · Cited by 61
Guo, R., Li, Y., Ning, J., Sun, D., Lin, L., & Liu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062729 · Cited by 60
Talwar, S., Balasubramanian, S., Sundaramurthy, S., House, R. P., Wilusz, C. J., Kuppuswamy, D., D’Silva, N. J., Gillespie, M. B., Hill, E. G., & Palanisamy, V. (2013) · RNA Biology · doi:10.4161/rna.23315 · Cited by 59
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients
Birzele, F., Voß, E., Nopora, A., Honold, K., Heil, F., Lohmann, S., Verheul, H. M. W., Tourneau, C. L., Delord, J., van Herpen, C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2141 · Cited by 59
Dalès, J.-P., Beaufils, N., Silvy, M., Picard, C., Pauly, V., Pradel, V., Formisano‐Tréziny, C., Bonnier, P., Giusiano, S., Charpin, C., et al. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-44 · Cited by 57
A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer1,2
Zhao, S., Chang, S. L., Linderman, J. J., Feng, F. Y.-C., & Luker, G. D. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.04.001 · Cited by 56
Planque, C., Choi, Y., Guyétant, S., Heuzé‐Vourc'h, N., Briollais, L., & Courty, Y. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.138917 · Cited by 56
Shieh, J., Liu, K.-T., Huang, S., Chen, Y., & Hsieh, T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.83 · Cited by 55
Deregulation of splicing factors and breast cancer development
Silipo, M., Gautrey, H., & Tyson-Capper, A. J. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv027 · Cited by 54
Identification of Novel Deregulated RNA Metabolism-Related Genes in Non-Small Cell Lung Cancer
Valles, I., Pajares, M. J., Segura, V., Guruceaga, E., Gómez‐Román, J., Blanco, D., Tamura, A., Montuenga, L. M., & Pı́o, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042086 · Cited by 54
Lin, K.-T., Shann, Y.-J., Chau, G.-Y., Hsu, C.-N., & Huang, C.-Y. F. (2013) · Oncogene · doi:10.1038/onc.2013.424 · Cited by 53
A splicing mutation in RB1 in low penetrance retinoblastoma
Schubert, E. L., Strong, L. C., & Hansen, M. F. (1997) · Human Genetics · doi:10.1007/s004390050551 · Cited by 51
Hong, J., Yuan, Y., Wang, J., Liao, Y., Zou, R., Zhu, C., Li, B., Liang, Y., Huang, P., Wang, Z., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2104 · Cited by 50
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy
Hahn, C. N., Venugopal, P., Scott, H. S., & Hiwase, D. (2014) · Immunological Reviews · doi:10.1111/imr.12241 · Cited by 49
Palve, V. C., Mallick, S., Ghaisas, G., Kannan, S., & Teni, T. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111927 · Cited by 49
mRNA Splicing Variants: Exploiting Modularity to Outwit Cancer Therapy
Dehm, S. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0444 · Cited by 47
Genome evolution predicts genetic interactions in protein complexes and reveals cancer drug targets
Lu, X., Kensche, P. R., Huynen, M. A., & Notebaart, R. A. (2013) · Nature Communications · doi:10.1038/ncomms3124 · Cited by 47
Expression analysis and functional activity of interleukin-7 splice variants
Vudattu, N. K., Magalhaes, I., Hoehn, H., Pan, D., & Maeurer, M. J. (2008) · Genes and Immunity · doi:10.1038/gene.2008.90 · Cited by 46
Splice isoforms as therapeutic targets for colorectal cancer
Miura, K., Fujibuchi, W., & Unno, M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs347 · Cited by 46
CD20 alternative splicing isoform generates immunogenic CD 4 helper T epitopes
Vauchy, C., Gamonet, C., Ferrand, C., Daguindau, É., Galaine, J., Beziaud, L., Chauchet, A., Henry, C., Deschamps, M., Rohrlich, P., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29366 · Cited by 45
Hartel, M., Narla, G., Wente, M. N., Giese, N. A., Martignoni, M. E., Martignetti, J. A., Friess, H., & Friedman, S. L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.030 · Cited by 45
Li, Z., Mou, H., Wang, T., Xue, J., Deng, B., Qian, L., Zhou, Y., Gong, W., Wang, J. M., Wu, G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.09.026 · Cited by 43
Increased levels of noisy splicing in cancers, but not for oncogene-derived transcripts
Chen, L., Tovar-Corona, J. M., & Urrutia, A. O. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr370 · Cited by 40
Alternative Splicing and Its Impact as a Cancer Diagnostic Marker
Kim, Y.-J., & Kim, H. (2012) · Genomics & Informatics · doi:10.5808/gi.2012.10.2.74 · Cited by 37
Bria, E., Modugno, F. D., Sperduti, I., Iapicca, P., Visca, P., Alessandrini, G., Antoniani, B., Pilotto, S., Ludovini, V., Vannucci, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2609 · Cited by 36
Jiang, S., Chen, H.-B., Dowdy, S. C., Fu, A., Attewell, J. R., Kalogera, E., Drapkin, R., Podratz, K. C., Broaddus, R. R., & Li, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122655 · Cited by 36
DDX 39 acts as a suppressor of invasion for bladder cancer
Kato, M., Wei, M., Yamano, S., Kakehashi, A., Tamada, S., Nakatani, T., & Wanibuchi, H. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02298.x · Cited by 35
Dorman, S., Viner, C., & Rogan, P. K. (2014) · Scientific Reports · doi:10.1038/srep07063 · Cited by 33
Thomas, M., Bayha, C., Klein, K., Müller, S., Weiß, T. S., Schwab, M. G., & Zanger, U. M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1500-x · Cited by 31
Modulation of RNA splicing as a potential treatment for cancer
Bauman, J. A., & Kole, R. (2011) · Bioengineered Bugs · doi:10.4161/bbug.2.3.15165 · Cited by 29
The exon‐level biomarker SLC39A14 has organ‐confined cancer‐specificity in colorectal cancer
Sveen, A., Bakken, A. C., Ågesen, T. H., Lind, G. E., Nesbakken, A., Nordgård, O., Brackmann, S., Rognum, T. O., Lothe, R. A., & Skotheim, R. I. (2011) · International Journal of Cancer · doi:10.1002/ijc.27399 · Cited by 25
Self-citationA novel transcript, VNN1‐AB , as a biomarker for colorectal cancer
Løvf, M., Nome, T., Bruun, J., Eknæs, M., Bakken, A. C., Mpindi, J. P., Kilpinen, S. K., Rognum, T. O., Nesbakken, A., Kallioniemi, O., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28855 · Cited by 20
Self-citationTranscriptome instability as a molecular pan-cancer characteristic of carcinomas
Sveen, A., Johannessen, B., Teixeira, M. R., Lothe, R. A., & Skotheim, R. I. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-672 · Cited by 20
Self-citationFusion gene microarray reveals cancer type‐specificity among fusion genes
Løvf, M., Thomassen, G. O. S., Bakken, A. C., Celestino, R., Fioretos, T., Lind, G. E., Lothe, R. A., & Skotheim, R. I. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20860 · Cited by 19
Self-citationHirschi, B., & Kolligs, F. T. (2013) · International Journal of Cancer · doi:10.1002/ijc.28061 · Cited by 15
Cited by
Next-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
Single-Cell RNA-Seq Technologies and Related Computational Data Analysis
Chen, G., Ning, B., & Shi, T. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00317 · Cited by 923
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
Uehara, T., Minoshima, Y., Sagane, K., Sugi, N. H., Mitsuhashi, K. O., Yamamoto, N., Kamiyama, H., Takahashi, K., Kotake, Y., Uesugi, M., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2363 · Cited by 396
Electrochemical biosensors for the detection of lung cancer biomarkers: A review
Khanmohammadi, A., Aghaie, A., Vahedi, E., Qazvini, A., Ghanei, M., Afkhami, A., Hajian, A., & Bagheri, H. (2020) · Talanta · doi:10.1016/j.talanta.2019.120251 · Cited by 358
Metadata
- Authors
- Sveen, A., Kilpinen, S., Ruusulehto, A., Lothe, R. A., & Skotheim, R. I.
- Venue
- Oncogene
- Published
- 2015-08-24
- Volume
- 35
- Issue
- 19
- Pages
- 2413-2427
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1883773314
- Cited by
- 470
- References
- 271
- FWCI
- 14.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.